{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:01:57Z","timestamp":1792652517021,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,5,3]],"date-time":"2005-05-03T00:00:00Z","timestamp":1115078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s00436-005-1339-1","type":"journal-article","created":{"date-parts":[[2005,5,3]],"date-time":"2005-05-03T09:27:16Z","timestamp":1115112436000},"page":"216-223","source":"Crossref","is-referenced-by-count":99,"title":["Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models"],"prefix":"10.1007","volume":"96","author":[{"given":"Anuradha","family":"Dube","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasib","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeloo","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,5,3]]},"reference":[{"key":"1339_CR1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","volume":"24","author":"JD Berman","year":"1997","unstructured":"Berman JD (1997) Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10\u00a0years. Clin Infect Dis 24:684\u2013703","journal-title":"Clin Infect Dis"},{"key":"1339_CR2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1128\/IAI.26.1.375-379.1979","volume":"26","author":"JD Berman","year":"1979","unstructured":"Berman JD, Dwyer DM, Weyler DJ (1979) Multiplication of Leishmania in human macrophages in vitro. Infect Immun 26:375\u2013379","journal-title":"Infect Immun"},{"key":"1339_CR3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF02705047","volume":"27","author":"A Bhattacharyya","year":"2002","unstructured":"Bhattacharyya A, Mukherjee M, Duttagupta S (2002) Studies on stibanate unresponsive isolates of Leishmania donovani. J Biosci 27:503\u2013508","journal-title":"J Biosci"},{"key":"1339_CR4","first-page":"62","volume":"12","author":"D Bora","year":"1999","unstructured":"Bora D (1999) Epidemiology of visceral leishmaniasis in India. Natl Med J India 12:62\u201368","journal-title":"Natl Med J India"},{"key":"1339_CR5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00436-002-0706-4","volume":"89","author":"MM Chan","year":"2003","unstructured":"Chan MM, Bulinski JC, Chang KP, Fong D (2003) A microplate assay for Leishmania amazonensis promastigotes expressing multimeric green fluorescent protein. Parasitol Res 89:266\u2013271","journal-title":"Parasitol Res"},{"key":"1339_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-3156.2001.00754.x","volume":"6","author":"SL Croft","year":"2001","unstructured":"Croft SL (2001) Monitoring drug resistance in leishmaniasis. Trop Med Int Health 6:1\u20137","journal-title":"Trop Med Int Health"},{"key":"1339_CR7","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1128\/AAC.45.12.3654-3656.2001","volume":"45","author":"SW Kamau","year":"2001","unstructured":"Kamau SW, Grimm F, Hehl AB (2001) Expression of green fluorescent protein as a marker for effects of antileishmanial compounds in vitro. Antimicrob Agents Chemother 45:3654\u20133656","journal-title":"Antimicrob Agents Chemother"},{"key":"1339_CR8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","volume":"180","author":"R Lira","year":"1999","unstructured":"Lira R, Sundar S, Makharia A, Keney R, Gam A, Saravia E, Sacks D (1999) Evidence that the high incidence of treatment failure in Indian kala-azar is due to the emergence of antimony resistant strains of Leishmania donovani. J Infect Dis 180:564\u2013567","journal-title":"J Infect Dis"},{"key":"1339_CR9","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","volume":"166","author":"PC Melby","year":"2001","unstructured":"Melby PC, Chandrasekar B, Zhao W, Coe JE (2001) The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J Immunol 166:1912\u20131920","journal-title":"J Immunol"},{"key":"1339_CR10","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.45.8.2185-2197.2001","volume":"45","author":"HW Murray","year":"2001","unstructured":"Murray HW (2001) Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob Agents Chemother 45:2185\u20132197","journal-title":"Antimicrob Agents Chemother"},{"key":"1339_CR11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jac\/14.5.463","volume":"14","author":"RA Neal","year":"1984","unstructured":"Neal RA, Croft SL (1984) An in vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani. J Antimicrob Chemther 14:463\u2013475","journal-title":"J Antimicrob Chemther"},{"key":"1339_CR12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/expr.2001.4598","volume":"97","author":"A Plock","year":"2001","unstructured":"Plock A, Sokolowska-Kohler W, Presber W (2001) Application of flow cytometry and microscopical methods to characterize the effects of herbal drugs on Leishmania spp. Exp Parasitol 97:141\u2013153","journal-title":"Exp Parasitol"},{"key":"1339_CR22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0924-8579(03)00125-0","volume":"22","author":"K Seifert","year":"2003","unstructured":"Seifert K, Matu S, Perez-Victoria FJ, Castanys S, Gamarro F, Croft SL (2003) Characterization of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). Int J Antimicrob Agents 22:380\u2013387","journal-title":"Int J Antimicrob Agents"},{"key":"1339_CR13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0001-706X(99)00048-0","volume":"74","author":"D Sereno","year":"2000","unstructured":"Sereno D, Holzmuller P, Lemesre JL (2000) Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum. Acta Trop 74:25\u201331","journal-title":"Acta Trop"},{"key":"1339_CR14","first-page":"101","volume":"83","author":"N Singh","year":"2002","unstructured":"Singh N (2002) Is there true Sb(V) resistance in Indian Kala azar field isoslates? Current Sci 83:101\u2013102","journal-title":"Current Sci"},{"key":"1339_CR15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4269\/ajtmh.2004.71.400","volume":"71","author":"Singh","year":"2004","unstructured":"Singh N, Dube A (2004) Fluorescent Leishmania: applications to antileishmanial drug testing. Am J Trop Med Hyg 71:400\u2013402","journal-title":"Am J Trop Med Hyg"},{"key":"1339_CR16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1179\/000349802125002257","volume":"96","author":"N Singh","year":"2002","unstructured":"Singh N, Singh RT, Sundar S (2002) Identification of a gene linked to drug resistance in field isolates of Leishmania donovani. Ann Trop Med Parasitol 96:839\u2013841","journal-title":"Ann Trop Med Parasitol"},{"key":"1339_CR17","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","volume":"6","author":"S Sundar","year":"2001","unstructured":"Sundar S (2001) Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 6:849\u2013854","journal-title":"Trop Med Int Health"},{"key":"1339_CR18","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","volume":"31","author":"S Sundar","year":"2000","unstructured":"Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, Kumar PC, Murray HW (2000) Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of Indian epidemic. Clin Infect Dis 31:1104\u20131107","journal-title":"Clin Infect Dis"},{"key":"1339_CR19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/00034983.1998.11813313","volume":"92","author":"CP Thakur","year":"1998","unstructured":"Thakur CP, Pandey AK, Kumar N, Kumar P, Hassan S, Narain S, Roy RK (1998) Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases. Ann Trop Med Parasitol 92:561\u2013569","journal-title":"Ann Trop Med Parasitol"},{"key":"1339_CR20","first-page":"159","volume":"40","author":"B Ullman","year":"1989","unstructured":"Ullman B, Carrero-Valenzuela E, Coons T (1989) Leishmania donovani: isolation and characterization of sodium stibogluconate (Pentostam) resistant cell lines. Exp Parasitol 40:159\u2013163","journal-title":"Exp Parasitol"},{"key":"1339_CR21","unstructured":"World Health organization, http:\/\/www.who.int\/mc\/diseases\/leish\/index.html"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-005-1339-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-005-1339-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-005-1339-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T05:21:09Z","timestamp":1586236869000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-005-1339-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,3]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["1339"],"URL":"https:\/\/doi.org\/10.1007\/s00436-005-1339-1","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,3]]}}}